Vaxcyte, Inc. (PCVX)
61.16
+0.06
(+0.11%)
USD |
NASDAQ |
Aug 27, 16:00
61.18
+0.02
(+0.04%)
After-Hours: 20:00
Vaxcyte 1 Year Total Returns (Daily) : 100.2% for Aug. 27, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 27, 2026 | 100.2% |
| August 26, 2026 | 102.0% |
| August 25, 2026 | 100.6% |
| August 24, 2026 | 91.61% |
| August 21, 2026 | 96.24% |
| August 20, 2026 | 96.23% |
| August 19, 2026 | 99.50% |
| August 18, 2026 | 86.32% |
| August 17, 2026 | 84.16% |
| August 14, 2026 | 84.76% |
| August 13, 2026 | 86.56% |
| August 12, 2026 | 98.83% |
| August 11, 2026 | 99.60% |
| August 10, 2026 | 94.95% |
| August 07, 2026 | 93.50% |
| August 06, 2026 | 78.45% |
| August 05, 2026 | 65.79% |
| August 04, 2026 | 62.19% |
| August 03, 2026 | 62.11% |
| July 31, 2026 | 59.29% |
| July 30, 2026 | 60.71% |
| July 29, 2026 | 52.77% |
| July 28, 2026 | 52.22% |
| July 27, 2026 | 51.52% |
| July 24, 2026 | 50.83% |
| Date | Value |
|---|---|
| July 23, 2026 | 52.61% |
| July 22, 2026 | 56.77% |
| July 21, 2026 | 62.85% |
| July 20, 2026 | 53.27% |
| July 17, 2026 | 50.39% |
| July 16, 2026 | 53.24% |
| July 15, 2026 | 60.83% |
| July 14, 2026 | 54.51% |
| July 13, 2026 | 58.73% |
| July 10, 2026 | 60.62% |
| July 09, 2026 | 67.22% |
| July 08, 2026 | 75.46% |
| July 07, 2026 | 89.59% |
| July 06, 2026 | 71.31% |
| July 02, 2026 | 75.50% |
| July 01, 2026 | 70.25% |
| June 30, 2026 | 78.81% |
| June 29, 2026 | 77.16% |
| June 26, 2026 | 71.90% |
| June 25, 2026 | 62.22% |
| June 24, 2026 | 58.02% |
| June 23, 2026 | 56.27% |
| June 22, 2026 | 58.53% |
| June 18, 2026 | 54.01% |
| June 17, 2026 | 50.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Moderna, Inc. | 468.8% |
| Arrowhead Pharmaceuticals, Inc. | 306.6% |
| Oncolytics Biotech, Inc. | -19.81% |
| Sangamo Therapeutics, Inc. | -71.51% |
| Sarepta Therapeutics, Inc. | 19.48% |